US Patent Issued to ENTOS PHARMACEUTICALS on Aug. 5 for "Recombinant oncolytic viruses for treatment of metastatic cancers" (Canadian, Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,289, issued on Aug. 5, was assigned to ENTOS PHARMACEUTICALS INC. (Edmonton, Canada).

"Recombinant oncolytic viruses for treatment of metastatic cancers" was invented by Roy Duncan (Mineville, Canada) and Chungen Pan (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are recombinant oncolytic viruses that express one or more reovirus fusion-associated small transmembrane FAST) proteins and uses thereof. The oncolytic activity of the recombinant oncolytic viruses expressing FAST proteins can be used to treat primary and metastatic cancers, especially from breast and colon cancers."

The patent was filed on June 22, 2018, under ...